Get the Stockscreener App
36.06
0.88%
-0.35
Lineage Inc stock is traded at $36.06, with a volume of 339.76K.
It is down -0.88% in the last 24 hours and up +4.10% over the past month.
Lineage Inc is a temperature-controlled warehouse real estate investment trust. It operates an interconnected global temperature-controlled warehouse network, comprising approximately millions of square feet across several warehouses predominantly located in densely populated critical-distribution markets across North America, Asia-Pacific, and Europe. The company's reportable segments are Global Warehousing, which utilizes the company's industrial real estate properties to provide temperature-controlled warehousing services to its customers, and Global Integrated Solutions, which complements Global Warehousing with specialized cold-chain services. Maximum revenue is generated from the Global Warehousing segment. Geographically, the company derives its key revenue from the United States.
See More
Previous Close:
$36.41
Open:
$36.32
24h Volume:
339.76K
Relative Volume:
0.24
Market Cap:
$8.23B
Revenue:
$5.30B
Net Income/Loss:
$-624.00M
P/E Ratio:
-11.75
EPS:
-3.0692
Net Cash Flow:
$42.00M
1W Performance:
+2.24%
1M Performance:
+4.10%
6M Performance:
-17.22%
1Y Performance:
-39.86%
1-Day Range:
$35.90
$36.48
1-Week Range:
$34.66
$36.94
52-Week Range:
$32.45
$62.30
Lineage Inc Stock (LINE) Company Profile
Name
Lineage Inc
Sector
Industry
Phone
(800) 678-7271
Address
46500 HUMBOLDT DRIVE, NOVI
Compare LINE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LINE
Lineage Inc
|
36.07 | 8.31B | 5.30B | -624.00M | 42.00M | -3.0692 |
|
PLD
Prologis Inc
|
127.10 | 117.44B | 8.79B | 3.57B | 4.27B | 3.5567 |
|
PSA
Public Storage
|
277.83 | 48.91B | 4.79B | 1.91B | 2.93B | 9.6238 |
|
EXR
Extra Space Storage Inc
|
139.49 | 29.73B | 3.34B | 997.83M | 1.73B | 4.4718 |
|
EGP
Eastgroup Properties Inc
|
179.19 | 9.48B | 679.77M | 236.60M | 385.49M | 4.6371 |
|
REXR
Rexford Industrial Realty Inc
|
39.40 | 9.18B | 903.94M | 275.97M | 94.31M | 1.23 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-06-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Jul-01-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-23-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-23-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-12-25 | Downgrade | BNP Paribas Exane | Neutral → Underperform |
| May-06-25 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-10-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-28-25 | Initiated | Citigroup | Neutral |
| Jan-14-25 | Initiated | Exane BNP Paribas | Neutral |
| Dec-20-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-18-24 | Initiated | CapitalOne | Overweight |
| Sep-16-24 | Initiated | CapitalOne | Overweight |
| Aug-19-24 | Initiated | Deutsche Bank | Hold |
| Aug-19-24 | Initiated | Evercore ISI | In-line |
| Aug-19-24 | Initiated | Goldman | Buy |
| Aug-19-24 | Initiated | JP Morgan | Overweight |
| Aug-19-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-19-24 | Initiated | Mizuho | Neutral |
| Aug-19-24 | Initiated | Morgan Stanley | Overweight |
| Aug-19-24 | Initiated | Piper Sandler | Overweight |
| Aug-19-24 | Initiated | Robert W. Baird | Outperform |
| Aug-19-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Initiated | Truist | Buy |
| Aug-19-24 | Initiated | UBS | Neutral |
| Aug-19-24 | Initiated | Wells Fargo | Equal Weight |
View All
Lineage Inc Stock (LINE) Latest News
U.S. Cold Storage Market to Reach US$ 91.4 Bn by 2032 as Key Players - openPR.com
Trade Report: Is Lineage Cell Therapeutics Inc a top pick in the sectorRisk Management & Verified Entry Point Detection - baoquankhu1.vn
Lineage, Inc. (NASDAQ:LINE) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Market Wrap: Can Lineage Inc deliver alphaDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
Market Moves: Is Lineage Cell Therapeutics Inc trading at a discountShare Buyback & Long-Term Safe Investment Plans - baoquankhu1.vn
What are the future prospects of Lineage Cell Therapeutics IncJuly 2025 Snapshot & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Guidance Update: Will Lineage Cell Therapeutics Inc stock hit new highs in YEARMarket Trend Review & Momentum Based Trading Signals - baoquankhu1.vn
Trade Recap: Will Lineage Cell Therapeutics Inc benefit from rising consumer demandTrade Exit Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Analysts Offer Insights on Real Estate Companies: Digital Realty (DLR) and Lineage, Inc. (LINE) - The Globe and Mail
What is Lineage Inc. s P E ratio telling usM&A Rumor & Safe Capital Growth Plans - mfd.ru
Lineage Therap Sells 12 Million Shares to Janus - MSN
Trading Recap: What are the analyst revisions for AFJKUIs Lineage Inc stock a good investment in YEARQuarterly Trade Review & Daily Oversold Bounce Ideas - baoquankhu1.vn
Aug Action: Can Lineage Inc be the next market leaderQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn
Aug Levels: Is GFL Environmental Inc stock showing strong momentum2025 Trading Recap & AI Based Trade Execution Alerts - baoquankhu1.vn
Travel Stocks: Can Lineage Inc outperform under higher oil pricesJuly 2025 Review & Community Driven Trade Alerts - baoquankhu1.vn
Assessing Lineage (LINE) Valuation As Analyst Downgrades Reset Market Expectations - simplywall.st
Lineage to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 25, 2026 - Business Wire
Market Overview: Should I average down on Lineage Cell Therapeutics Inc stockEarnings Trend Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Lineage (NASDAQ:LINE) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
The Bull Case For Lineage (LINE) Could Change Following Barclays Downgrade And Rising Analyst Caution - Sahm
Lineage Takes Delivery of Genetically Engineered iPSC Line with Hypoimmunity Edits from Factor Bioscience - BioInformant
Aug PostEarnings: Can Lineage Cell Therapeutics Inc stock outperform in 2025 bull market - moha.gov.vn
Lineage Shares Fall After Barclays Downgrade - marketscreener.com
Aug Sentiment: Will Lineage Inc stock deliver strong dividend growth2025 Valuation Update & Long Hold Capital Preservation Plans - moha.gov.vn
LINE: Barclays Downgrades Lineage, Lowers Price Target to $38.00 - GuruFocus
Lineage (NASDAQ:LINE) Given "Equal Weight" Rating at Barclays - MarketBeat
Barclays Downgrades Lineage to Equalweight From Overweight, Lowers Price Target to $38 From $47 - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Shareholders to Connect - ACCESS Newswire
Aug Update: Why hedge funds are buying Lineage Inc stockTrade Entry Summary & Community Verified Swing Trade Signals - moha.gov.vn
Lineage, Inc. Prices €700M Senior Notes Offering - MSN
CEO Moves: Why Lineage Cell Therapeutics Inc stock remains a top recommendationMarket Movers & Verified Momentum Stock Alerts - moha.gov.vn
What dividend safety score for Lineage Cell Therapeutics Inc. stock2025 Geopolitical Influence & Safe Entry Point Alerts - ulpravda.ru
Why hedge funds are buying Lineage Inc. stockJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Shareholders to Reach Out - ACCESS Newswire
Will Lineage Inc. stock benefit from automationMarket Performance Recap & Risk Managed Investment Signals - ulpravda.ru
What dividend safety rating applies to Lineage Cell Therapeutics Inc. stock2025 Technical Overview & Target Return Focused Picks - ulpravda.ru
Why Lineage Cell Therapeutics Inc. stock is a must watch in 2025Earnings Beat & AI Powered Market Entry Strategies - ulpravda.ru
Earnings Miss: Can Lineage Cell Therapeutics Inc. stock resist sector downturnsJuly 2025 Gainers & Reliable Entry Point Trade Alerts - ulpravda.ru
CEO Change: What dividend safety rating applies to Lineage Cell Therapeutics Inc. stock2025 AllTime Highs & Daily Stock Trend Reports - ulpravda.ru
Can Lineage Inc. stock surprise with earnings upsideLow Beta Stocks & Free Superior Stock Performance - ulpravda.ru
US Cold Storage Market 2026-2033: Growth Overview, Facts & - openPR.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lineage, Inc. (LINE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience - PharmiWeb.com
Lineage Cell Therapeutics highlights 2025 achievements in cell therapy - Investing.com
Lineage Cell Therapeutics Issues Letter to Stockholders - Business Wire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lineage, Inc. (LINE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Aug Opening: Can Hawaiian Electric Industries Inc stock withstand sector downturnsJuly 2025 Gainers & Accurate Intraday Trading Signals - moha.gov.vn
Lineage, Inc. (LINE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lineage, Inc. (NASDAQ:LINE) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
Meme Stocks: Can Lineage Inc stock resist market sell offsGap Down & Free High Return Stock Watch Alerts - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Investors to Connect - ACCESS Newswire
Lineage Inc Stock (LINE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):